Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for ...

Advocates celebrate 2023 legislation capping insulin prices for people on the state employee health insurance plan in a ...

Investing.com – Denmark stocks were lower after the close on Friday, as losses in the Oil & Gas, Financials and Real Estate sectors led shares lower. At the close in Copenhagen,... Investing.com ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Tens of Thousands Ordered to Flee From L.A. Fire Pacific Palisades, Calif. LIVE Homes Destroyed as Officials Warn Worst Is Yet to Come Rapidly moving flames fanned by strong Santa Ana winds ...